Cargando…

Quality assurance in specialized headache units in Spain: an observational prospective study

OBJECTIVE: To assess the quality of the therapeutic approach in Specialized Headache Units in Spain. METHODS: An observational (prospective) study was conducted. Anonymized data of 313 consecutive patients during a defined period of time were analyzed and a comparison of performance in 13 consensual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozo-Rosich, Patricia, Martínez-García, Alba, Pascual, Julio, Ignacio, Emilio, Guerrero-Peral, Ángel L., Balseiro-Gómez, José, Porta-Etessam, Jesús, Latorre-González, Germán, Layos-Romero, Almudena, Lucas, César, Mira, José J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734389/ https://www.ncbi.nlm.nih.gov/pubmed/31238877 http://dx.doi.org/10.1186/s10194-019-1020-1

Ejemplares similares

Low-value care practice in headache: a Spanish mixed methods research study
por: Pozo-Rosich, Patricia, et al.
Publicado: (2020)

Proposal of a clinical care pathway for quality and safe management of headache patients: a consensus study report
por: Pascual, Julio, et al.
Publicado: (2020)

Persistent headache after COVID-19: Pathophysioloy, clinic and treatment
por: Membrilla, J.A., et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives()
por: López-Bravo, A., et al.
Publicado: (2020)

A patient with primary sexual headache associated with hypnic headaches
por: Porta-Etessam, Jesús, et al.
Publicado: (2009)

Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain
por: Guerrero-Peral, Ángel Luis, et al.
Publicado: (2022)

OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection()
por: Santos-Lasaosa, S., et al.
Publicado: (2020)

Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research
por: Caronna, Edoardo, et al.
Publicado: (2021)

EHMTI-0103. Errors in recognition and management are still frequent in cluster headache
por: del Río, M Sánchez, et al.
Publicado: (2014)

Tension-type headache in the Emergency Department Diagnosis and misdiagnosis: The TEDDi study
por: García-Azorín, D., et al.
Publicado: (2020)

Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis
por: Planchuelo-Gómez, Álvaro, et al.
Publicado: (2020)

Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA
por: Torres-Ferrus, Marta, et al.
Publicado: (2020)

Orthostatic headache and bilateral abducens palsy secondary to spontaneous intracranial hypotension
por: Porta-Etessam, Jesús, et al.
Publicado: (2010)

Are Cox-2 drugs the second line option in indomethacin responsive headaches?
por: Porta-Etessam, Jesús, et al.
Publicado: (2010)

Understanding the diagnoses and medical care experience of patients with new daily persistent headache: a qualitative study in Spain
por: Palacios-Ceña, Domingo, et al.
Publicado: (2021)

Presence of red flags in patients with cerebral venous sinus thrombosis admitted to the emergency department because of headache: A STROBE compliant cohort-study
por: García-Azorín, David, et al.
Publicado: (2020)

Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
por: Reuter, Uwe, et al.
Publicado: (2019)

InterMiG: international differences in the therapeutic approach to migraine patients in specialized headache centers
por: Gago-Veiga, AB, et al.
Publicado: (2021)

Driver Liability Assessment in Vehicle Collisions in Spain
por: Sanjurjo-de-No, Almudena, et al.
Publicado: (2021)

EHMTI-0273. Onabotulinotoxin type A is a therapeutic option in chronic cluster headache
por: Mas-Sala, N, et al.
Publicado: (2014)

Special Issue “Clinical Advances in Chronic Intestinal Diseases Treatment”
por: Latorre, Eva, et al.
Publicado: (2022)

Treatment of chronic daily headache
por: Pascual, Julio
Publicado: (2004)

Interest in and exposure to headache disorders among neurology residents in Denmark: A nationwide cross‐sectional survey
por: Kristensen, Malene Glavind Holmsted, et al.
Publicado: (2022)

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
por: Matharu, Manjit, et al.
Publicado: (2017)

Galeata: chronic migraine independently considered in a medieval headache classification
por: Guerrero-Peral, Ángel Luís, et al.
Publicado: (2014)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

Measures to Assure that Ebola Guidelines Are Correctly Applied
por: Mira, José Joaquín, et al.
Publicado: (2016)

Special Colloquium - "That's the story"
por: Latorre, Jose I.
Publicado: (2014)

Variables associated with use of symptomatic medication during a headache attack in individuals with tension-type headache: a European study
por: Fernández-de-las-Peñas, César, et al.
Publicado: (2020)

Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas
por: Irimia, P., et al.
Publicado: (2021)

More lessons for the treatment of chronic daily headache
por: Pascual, Julio, et al.
Publicado: (2008)

The association of headache frequency with pain interference and the burden of disease is mediated by depression and sleep quality, but not anxiety, in chronic tension type headache
por: Palacios-Ceña, María, et al.
Publicado: (2017)

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
por: Montero-Escribano, Paloma, et al.
Publicado: (2020)

International Adoption of Children with Special Needs in Spain
por: Hernanz Lobo, Alicia, et al.
Publicado: (2023)

Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine
por: Porta-Etessam, J., et al.
Publicado: (2023)

Neuroimaging, neuropsychological and psychopathological findings in Medication Overuse Headache (MOH) before and after detoxification
por: Pozo-Rosich, P, et al.
Publicado: (2013)

Prevalence of primary headaches: it is not the behavior, but still we have to pay attention to it!
por: Pascual, Julio
Publicado: (2011)

European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
por: Sacco, Simona, et al.
Publicado: (2020)

Special Contribution from Spain
Publicado: (1960)

Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2uo3h0fo40v94q1c1q477t7u1g